[ad_1]
ReNeuron Group PLC (LON: RENE), Michael Hunt, is discussing with Andrew Scott of Proactive London a signed contract that could potentially yield up to £ 80 million in payments based on success with the company. one of the leading drug manufacturers in China.
Fosun Pharma licenses the rights to the company's CTX and hRPC cell therapy programs in the People's Republic for an initial £ 6 million.
Source link
